Proactive Investors - Run By Investors For Investors

Havilah Resources fast-tracks North Portia sale agreement with common sense revision

Havilah Resources Ltd (ASX:HAV) technical director Chris Giles updates Proactive Investors on the exploration company's revised North Portia sale agreement.
 
"For us a big improvement is more cash up-front, so we've already been paid $2 million and a further $4 million is due in July," says Giles.
 
He adds that the revised deal relieves the company of permitting responsibilities and creates certainty of income, and looking at it on any valuation metric, represents a fair price and a good deal for Havilah.
 
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event, London , 11 July 2019. Register here »
View full HAV profile View Profile

Havilah Resources Ltd Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use